Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin T King

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
National Trends and Predictors of Androgen Deprivation Therapy Use in Low-Risk Prostate CancerDavid D Yang, Vinayak Muralidhar, Brandon A Mahal, et al.
Brachytherapy|September 12, 2021
Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statementMartin T King, Mira Keyes, Steven J Frank, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 19, 2025
CT online adaptive radiotherapy is associated with dosimetric and acute toxicity improvements in prostate cancer treatmentLin L Zhu, Jeremy S Bredfeldt, Yue-Houng Hu, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Immune Spatial Organization Predicts Metastasis Risk in Aggressive Localized Prostate CancerDavid D Yang, Aya Abdelnaser, Jeremiah Wala, et al.
European Urology Focus|July 30, 2017
Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3+4 Favorable Intermediate-risk Prostate CancerDavid D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
European Urology Oncology|November 15, 2024
Combined Fixed-duration Systemic Treatment and Metastasis-directed Radiotherapy for Oligometastatic Hormone-sensitive Prostate CancerPraful Ravi, Caiwei Zhong, Wanling Xie, et al.
Gynecologic Oncology|March 9, 2025
Role of adjuvant radiotherapy modality on clinical outcomes for early-stage uterine carcinosarcomaKevin Tyan, Kevin X Liu, Alicia C Smart, et al.
Urologic Oncology|May 24, 2017
Low rates of androgen deprivation therapy use with salvage radiation therapy in patients with prostate cancer after radical prostatectomyDavid D Yang, Vinayak Muralidhar, Brandon A Mahal, et al.
Radiology|October 29, 2024
AI-derived Tumor Volume from Multiparametric MRI and Outcomes in Localized Prostate CancerDavid D Yang, Leslie K Lee, James M G Tsui, et al.
JAMA Oncology|February 9, 2023
Hyaluronic Acid Spacer for Hypofractionated Prostate Radiation Therapy: A Randomized Clinical TrialNeil F Mariados, Peter F Orio, Zvi Schiffman, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
National Trends and Predictors of Androgen Deprivation Therapy Use in Low-Risk Prostate CancerDavid D Yang, Vinayak Muralidhar, Brandon A Mahal, et al.
Brachytherapy|September 12, 2021
Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statementMartin T King, Mira Keyes, Steven J Frank, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 19, 2025
CT online adaptive radiotherapy is associated with dosimetric and acute toxicity improvements in prostate cancer treatmentLin L Zhu, Jeremy S Bredfeldt, Yue-Houng Hu, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Immune Spatial Organization Predicts Metastasis Risk in Aggressive Localized Prostate CancerDavid D Yang, Aya Abdelnaser, Jeremiah Wala, et al.
European Urology Focus|July 30, 2017
Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3+4 Favorable Intermediate-risk Prostate CancerDavid D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
European Urology Oncology|November 15, 2024
Combined Fixed-duration Systemic Treatment and Metastasis-directed Radiotherapy for Oligometastatic Hormone-sensitive Prostate CancerPraful Ravi, Caiwei Zhong, Wanling Xie, et al.
Gynecologic Oncology|March 9, 2025
Role of adjuvant radiotherapy modality on clinical outcomes for early-stage uterine carcinosarcomaKevin Tyan, Kevin X Liu, Alicia C Smart, et al.
Urologic Oncology|May 24, 2017
Low rates of androgen deprivation therapy use with salvage radiation therapy in patients with prostate cancer after radical prostatectomyDavid D Yang, Vinayak Muralidhar, Brandon A Mahal, et al.
Radiology|October 29, 2024
AI-derived Tumor Volume from Multiparametric MRI and Outcomes in Localized Prostate CancerDavid D Yang, Leslie K Lee, James M G Tsui, et al.
JAMA Oncology|February 9, 2023
Hyaluronic Acid Spacer for Hypofractionated Prostate Radiation Therapy: A Randomized Clinical TrialNeil F Mariados, Peter F Orio, Zvi Schiffman, et al.
Pageof 7